Percutaneous closure of left ventricle pseudoaneurysm using 3D printed heart model for procedure planning: A novel approach

Mohamed, Elsayed; Telila, Tesfaye; Osaki, Satoru; Jacobson, Kurt

doi:10.1002/ccd.28405

Cited by 5 publications

(8 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A mural thrombus inside the LVPA was found in 7 (7.5%) patients [ 13 , 14 , 25 , 29 , 31 , 38 , 46 ]. Three (42.9%) of these thrombosed LVPAs were recurrent [ 13 , 29 , 31 ].…”

Section: Resultsmentioning

confidence: 99%

“…Effects of percutaneous closure for LVPA cavity were reported as follows: complete exclusion of the LVPA ( n = 8) [ 7 , 12 , 15 , 28 , 33 , 44 , 45 , 50 ], complete thrombosis of LVPA with no residual flow ( n = 7) [ 11 , 26 , 34 , 41 , 46 , 55 , 61 ], contraction of the pseudoaneurysm ( n = 1) [ 69 ], partial thrombosis of LVPA ( n = 1) [ 7 ], no blood communication to LVPA by thrombin injection [ 51 , 37 ], large LVPA sacs filled with embolisation coils ( n = 3) [ 37 ], LVPV reduced in diameter [ 6 ], and LVPA persistent but not increasing in size and partially thrombosed [ 39 ].…”

Section: Resultsmentioning

confidence: 99%

Section: (19)mentioning

confidence: 99%

See 2 more Smart Citations

Percutaneous closure of left ventricular pseudoaneurysm

Yuan¹

2022

pwki

View full text Add to dashboard Cite

The aim of the present study is to describe the indications, treatment effects, and patient outcomes of percutaneous management of left ventricular pseudoaneurysm (LVPA). The study materials were based on comprehensive literature retrieval since 2004. The mechanisms of LVPA formation can be divided into surgical, percutaneous, and medial disease related. Of the surgical mechanisms, coronary artery bypass grafting prevailed. The formation time was the longest in medical disease-related LVPAs up to 44.4 months. The percutaneous procedures succeeded on the first try in 79 (84.9%) patients, whereas failures were encountered during the percutaneous manoeuvres in 14 (15.1%) patients. Percutaneous closure of LVPA was especially indicated for patients carrying a high surgical risk. The iatrogenic traumas, such as left ventricular venting, should be avoided to prevent this complication. The preliminary cut-off valves of oversize 3.3 mm and oversize ratio 1.6 should be followed for reference for device choice.

show abstract

“…A mural thrombus inside the LVPA was found in 7 (7.5%) patients [ 13 , 14 , 25 , 29 , 31 , 38 , 46 ]. Three (42.9%) of these thrombosed LVPAs were recurrent [ 13 , 29 , 31 ].…”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Percutaneous closure of left ventricular pseudoaneurysm

Yuan¹

2022

pwki

View full text Add to dashboard Cite

show abstract

“…Additionally, CFWR may occur as a complication of cardiac-based procedure or trauma [4,12]. Significant advancements and increasing use of cardiac-based procedure, such as cardiac catheterization, patent foramen ovale closure, left atrial appendage closure, defibrillator placement, and pericardiocentesis has resulted in an increased incidence of CFWR [4,[13][14][15][16][17][18][19][20][21][22][23][24][25].…”

Section: Discussionmentioning

confidence: 99%

Employing Amplatzer Occluder® in Cardiac Free Wall Rupture Repair: A Scoping Study

Kariyanna¹,

Tadayoni²,

Jayarangaiah³

et al. 2020

AJMCR

View full text Add to dashboard Cite

Cardiac free wall rupture (CFWR) is an uncommon complication of myocardial infarction, cardiacbased procedures, and blunt chest trauma. Cardiac tamponade and shock which occurs as a result of CFWR results in a high mortality rate. Despite the high mortality rate, there is a window of opportunity for intervention in selected patients with acute or subacute free wall rupture. Hence, prompt diagnosis and intervention are key to prevent cardiac tamponade and death. Even though emergency surgical repair is the standard treatment for the CWFR, the catheter-based procedure has provided an alternative treatment option, especially, in the high-risk surgical patients. For instance, Amplatzer occluder® (AO), a device which is used in repairing congenital septal wall defect, is being used as an alternative method of treatment in CFWR. In this systemic review, we assessed the 19 cases of CFWR occurring after invasive cardiac procedures who underwent repair with the utilization of AO®. The study shows that the successful rate of percutaneous closure of CFWR was 84.3% (16/19) with a mortality rate of 15.7% (3/19) in this cohort. Therefore, the in-hospital mortality rate of CFWR closure is comparable with the average in-house mortality rate of emergency surgical repair which is 14%. Furthermore, we found that AO® placement technique has a lower mortality rate compared to the other less-invasive methods such as percutaneous intrapericardial fibrin-glue injection which has a mortality rate of 25%. In conclusion, employing AO® in CFWR repair not only serves as the treatment of choice in the high-risk surgical candidates but could also be applied as an alternative method in the general population. However, further studies are required to assess the outcome and mortality rate of using AO® in CFWR to provide us with a more consistent and accurate data.

show abstract

“…Furthermore, 3DPSP were evaluated as helpful in the planning of adult cardiothoracic surgery [64], post-infarct VSD [65], cardiac resynchronisation device lead implantation [66], or the treatment of complex cardiac fistulae [67]. Other case reports and case series described the emerging role of 3DPSP in left ventricular pseudoaneurysm [68][69][70] and aneurysm of congenital origin [71]. Successful planning of valve interventions others than CHD, TAVI, and mitral valve repair/ replacement (MVR) on 3DPSP were described during Ozaki repairs of the aortic valve [72], tricuspid valve-in-valve replacement [73], surgical tricuspid valve repair [74], and transcatheter tricuspid valve repair by MitraClip (Abbott, Menlo Park, CA, USA) implantation [75].…”

Section: Other Interventionsmentioning

confidence: 99%

Imaging-Based, Patient-Specific Three-Dimensional Printing to Plan, Train, and Guide Cardiovascular Interventions: A Systematic Review and Meta-Analysis

Bernhard

Illi

Gloeckler

et al. 2022

Heart, Lung and Circulation

View full text Add to dashboard Cite

Percutaneous closure of left ventricle pseudoaneurysm using 3D printed heart model for procedure planning: A novel approach

Abstract: Left ventricle pseudoaneurysm is a rare complication of myocardial infarction that carries a high risk of mortality. In this report, we present a case of successful percutaneous closure of left ventricle pseudoaneurysm using 3D printing for procedure guidance.

Cited by 5 publications

References 4 publications

Percutaneous closure of left ventricular pseudoaneurysm

Percutaneous closure of left ventricular pseudoaneurysm

Employing Amplatzer Occluder® in Cardiac Free Wall Rupture Repair: A Scoping Study

Imaging-Based, Patient-Specific Three-Dimensional Printing to Plan, Train, and Guide Cardiovascular Interventions: A Systematic Review and Meta-Analysis

Contact Info

Product

Resources

About